Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

GLOBAL: New Hepatitis B Vaccine Developed (08.12.2013)

The Israeli drug manufacturer SciVac has developed a new third-generation hepatitis B vaccine that the company believes would halt global growth of the virus. The medical community has used the current second-generation vaccine for more than 20 years; according to SciVac, 10 percent of newborns and 25 percent of adults older than 40 do not respond to it. SciVac Chief Executive Officer Michal Ben Attar stated that the new vaccine was 100-percent effective against hepatitis B. The drug manufacturer has applied to the US Food and Drug Administration for permission to distribute the vaccine; if granted, SciVac also will seek approval in Europe.


Copyright © 2013 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

Information in this article was accurate in August 14, 2013. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.